Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.915 USD | +8.15% | +11.02% | -14.57% |
05-14 | Transcript : NRx Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
05-06 | NRx Pharmaceuticals Shares Rise 38% After Positive Drug Trial Data | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.57% | 37.73M | |
+67.40% | 62.86B | |
-0.90% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+14.10% | 26.46B | |
-22.82% | 18.9B | |
+4.69% | 12.67B | |
+23.61% | 12.27B | |
+28.20% | 12.07B |
- Stock Market
- Equities
- BRPA Stock
- News NRx Pharmaceuticals, Inc.
- NRx Pharmaceuticals Appoints Seth Van Voorhees Finance Chief